Patent details

EN | LT

LT - CRYSTALLINE FORMS AND TWO SOLVATED FORMS OF 4-AMINO-5-FLUORO-3-[5-(4-METHYLPIPERAZIN-1-YL)-1H-BENZIMIDAZOL-2-YL]QUINOLIN-2(1H)-ONE LACTIC ACID SALTS

EN - CRYSTALLINE FORMS AND TWO SOLVATED FORMS OF 4-AMINO-5-FLUORO-3-[5-(4-METHYLPIPERAZIN-1-YL)-1H-BENZIMIDAZOL-2-YL]QUINOLIN-2(1H)-ONE LACTIC ACID SALTS

Legal status

Patent not validated

Bibliographic data

Indications of the International Patent Classification (IPC)
(51)	INT.CL.	C07D 401/14
		A61K 31/496
		A61P 35/00

European patent
(11)	Number of the document	2257544
(13)	Kind of document	T
(96)	European patent application number	09721534.7
	Date of filing the European patent application	2009-03-18
(97)	Date of publication of the European application	2010-12-08
(45)	Date of publication and mention of the grant of the patent	2014-12-03
(46)	Date of publication of the claims translation

PCT application
(86)	Number	PCT/EP2009/053222
	Date	2009-03-18

PCT application publication
(87)	Number	WO 2009/115562
	Date	2009-09-24

Priority applications
(30)	Number	Date	Country code
	37746 P	2008-03-19	US

Inventors
(72)	GIRON, Danielle, FR HAMMERSCHMIDT, Walter, CH PIECHON, Philippe, FR POLASEK, Johanne, CH SCHREINER, Andreas, CH STOWASSER, Frank, DE

Grantee
(73)	Novartis AG, Lichtstrasse 35, 4056 Basel, CH

Title
(54)	CRYSTALLINE FORMS AND TWO SOLVATED FORMS OF 4-AMINO-5-FLUORO-3-[5-(4-METHYLPIPERAZIN-1-YL)-1H-BENZIMIDAZOL-2-YL]QUINOLIN-2(1H)-ONE LACTIC ACID SALTS
	CRYSTALLINE FORMS AND TWO SOLVATED FORMS OF 4-AMINO-5-FLUORO-3-[5-(4-METHYLPIPERAZIN-1-YL)-1H-BENZIMIDAZOL-2-YL]QUINOLIN-2(1H)-ONE LACTIC ACID SALTS